News

Hollings researchers uncovered data showing that women who survive cervical cancer are at greater risk of anal cancer years down the road.

A clinical trial at Hollings is looking for answers to a problem that Dr. Avi Siva saw was affecting her triple negative breast cancer patients.

Researchers find a nuanced approach to treating intracranial internal carotid artery aneurysms can be done safely and may get better outcomes.

MUSC study finds a link between inflammation and poor neonatal and pregnancy outcomes.

A new microcredential from Hollings Cancer Center highlights the work of future cancer researchers, who are learning both science and compassion.

As people across country cope with aftermath of shooting that killed two children during a Catholic Mass, MUSC-based center is helping with recovery.

MUSC Hollings Cancer Center researchers are working on a new drug that destroys cancer cells' energy factories.

New trial to test whether quit-smoking medication works to help people to quit vaping.

MUSC students receive world-class training and make worldwide connections at an international redox training program in Hungary.

MUSC student Thomas Blouin will use an NCI fellowship to study how a chemical that doesn't seem to change DNA still causes cancer.